首页 › 甲状腺癌 › 纽约州 › New York City
New York City NY 甲状腺癌临床试验
9项针对 甲状腺癌的研究正在 New York City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
招募中1/2 期
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Memorial Sloan Kettering Cancer Center, New York
Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
招募中1 期
- Memorial Sloan Kettering Cancer Center, New York
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
招募中
- Memorial Sloan Kettering Cancer Center, New York
A Study of Avutometinib and Defactinib in People With Thyroid Cancer
招募中2 期
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Environmental Factors and Thyroid Cancer
招募中观察性研究
- Icahn School of Medicine at Mount Sinai, New York
Brodalumab in the Treatment of Immune-Related Adverse Events
招募中1 期
- Columbia University Irving Medical Center, New York
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
招募中观察性研究
- Memorial Sloan Kettering Cancer Center, New York
New MRI Biomarkers in Head and Neck Cancers
招募中观察性研究
- Memorial Sloan Kettering Cancer Center, New York
其他城市的 甲状腺癌试验
- Houston, TX12 项研究
- Washington, DC10 项研究
- Boston, MA6 项研究
- Philadelphia, PA6 项研究
- Durham, NC5 项研究
- Nashville, TN5 项研究
- Los Angeles, CA5 项研究
- St. Louis, MO4 项研究
- Memphis, TN4 项研究
- Ann Arbor, MI4 项研究
- San Antonio, TX4 项研究
- Minneapolis, MN4 项研究
New York City的其他研究
- 乳腺癌136 项研究
- 非小细胞肺癌121 项研究
- 癌症（所有类型）109 项研究
- 前列腺癌103 项研究
- 转移性癌症93 项研究
- 结直肠癌78 项研究
- 卵巢癌69 项研究
- 肺癌60 项研究
- 多发性骨髓瘤60 项研究
- 胰腺癌60 项研究
- 子宫内膜癌52 项研究
- 急性髓系白血病51 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。